Healthcare providers should counsel patients that these products are not substitutes for evidence-based weight management strategies or prescription medications when clinically indicated
however, the average BMI plateaued in 2022 and declined in 2023 (Rader et al., 2024)
Women are far less hesitant to seek a physicians help with weight loss and management, they said
Dr Packer has served as a consultant for 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, Armgo, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Lilly, Imara, Medtronic, Moderna, Novartis, Pharmacocosmos, Reata, Regeneron, Roche, and Salamandra
Regulatory rules are in flux, and product quality is all over the map